OIM
XBIT icon

Oracle Investment Management’s XBiotech XBIT Stock Holding History

Oracle Investment Management’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-500,000
Closed -$674K – 41
2021
Q4 		$674K Buy
+500,000
New +$6.51M 0.1% 25

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Oracle Investment Management's XBIT Position: Q4 2021 in Review

Oracle Investment Management sold out of XBiotech (XBIT) in Q4 2021, closing a stake of 350,000 shares — an estimated $4.56M sold.

Oracle Investment Management first reported a position in XBIT in Q3 2021 and held it in 1 quarter. The position peaked at $275K in Q3 2021. 61 funds tracked by Wall St. Rank hold XBIT as of Q4 2021.

  • Oracle Investment Management reported no remaining XBiotech position as of Q4 2021 after selling out during the quarter.
  • Oracle Investment Management sold 350,000 XBiotech shares in Q4 2021, an estimated $4.56M.
  • Oracle Investment Management first reported a position in XBiotech in Q3 2021 and held it in 1 quarter.
  • Oracle Investment Management's XBiotech position peaked at $275K in Q3 2021.
  • 61 funds tracked by Wall St. Rank held XBiotech as of Q4 2021.

Based on Oracle Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.